
Sign up to save your podcasts
Or
Around the world, the race is on to develop a Covid-19 vaccine. So far, nearly 200 candidates are in the works, including dozens at the human-trial stage. The optimistic experts tell us that a vaccine could be ready this year or early next, and set for distribution by mid-to-late 2021. The pessimists suggest it could take longer. But few doubt that we will be able to produce a vaccine.
The question of concern, therefore, is not whether we’ll develop a Covid-19 vaccine or whether it will be safe and effective. The question of concern is ‘Who will get the Covid-19 vaccine--and when?’
On this episode of Open to Debate, David Moscrop talks with Dr. Alan Bernstein, president and CEO of the Canada-based global research organization CIFAR and member of Canada’s Covid-19 vaccine task force.
3.2
1111 ratings
Around the world, the race is on to develop a Covid-19 vaccine. So far, nearly 200 candidates are in the works, including dozens at the human-trial stage. The optimistic experts tell us that a vaccine could be ready this year or early next, and set for distribution by mid-to-late 2021. The pessimists suggest it could take longer. But few doubt that we will be able to produce a vaccine.
The question of concern, therefore, is not whether we’ll develop a Covid-19 vaccine or whether it will be safe and effective. The question of concern is ‘Who will get the Covid-19 vaccine--and when?’
On this episode of Open to Debate, David Moscrop talks with Dr. Alan Bernstein, president and CEO of the Canada-based global research organization CIFAR and member of Canada’s Covid-19 vaccine task force.
394 Listeners
227 Listeners
42 Listeners
80 Listeners
56 Listeners
115 Listeners
29 Listeners
105 Listeners
418 Listeners
254 Listeners
91 Listeners
124 Listeners
45 Listeners
14 Listeners
13 Listeners